Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay
Top Cited Papers
Open Access
- 1 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 56 (2), 254-261
- https://doi.org/10.1373/clinchem.2009.132654
Abstract
Background: We report the development of a novel high-sensitivity cardiac troponin T (hs-cTnT) assay, a modification of the Roche fourth-generation cTnT assay, and validation of the analytical performance of this assay. Methods: Validation included testing of analytical sensitivity, specificity, interferences, and precision. We established the 99th percentile cutoff from healthy reference populations (n = 616). In addition, we studied differences in time to a positive result when using serial measurements of hs-cTnT vs cTnT in patients with a confirmed diagnosis of non-ST elevation myocardial infarction (non-STEMI). Results: The hs-cTnT assay had an analytical range from 3 to 10 000 ng/L. At the 99th percentile value of 13.5 ng/L, the CV was 9% using the Elecsys® 2010 analyzer. The assay was specific for cTnT without interferences from human cTnI or cTnC, skeletal muscle TnT, or hemoglobin concentrations up to 1000 mg/L, above which falsely lower values would be expected. When the assay was evaluated clinically, a hs-cTnT higher than the 99th percentile concentration identified a significantly higher number of patients with non-STEMI on presentation (45 vs 20 patients, P = 0.0004) compared with cTnT, and a final diagnosis of non-STEMI was made in 9 additional patients (55 vs 46 patients, P = 0.23) after serial sampling. Time to diagnosis was significantly shorter using hs-cTnT compared with cTnT [mean 71.5 (SD 108.7) min vs 246.9 (82.0) min, respectively; P < 0.01]. Conclusions: The analytical performance of hs-cTnT complies with the ESC-ACCF-AHA-WHF Global Task Force recommendations for use in the diagnosis of MI.Keywords
Funding Information
- Roche
- Siemens
- AstraZeneca
This publication has 20 references indexed in Scilit:
- Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial InfarctionThe New England Journal of Medicine, 2009
- Minimally Elevated Cardiac Troponin T and Elevated N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality in Older Adults: Results From the Rancho Bernardo StudyJournal of the American College of Cardiology, 2008
- Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjectsEuropean Heart Journal, 2008
- Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertensionEuropean Respiratory Journal, 2008
- Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart FailureCirculation, 2007
- Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2007
- Long-Term Health Outcomes Associated with Detectable Troponin I ConcentrationsClinical Chemistry, 2007
- NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patientsEuropean Heart Journal, 2005
- Impact of the troponin standard on the prevalence of acute myocardial infarctionAmerican Heart Journal, 2003
- Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2000